{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:29:27Z","timestamp":1790857767485,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":7555,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1038\/ki.1995.166","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T17:08:07Z","timestamp":1179767287000},"page":"1168-1175","source":"Crossref","is-referenced-by-count":22,"title":["Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis"],"prefix":"10.1016","volume":"47","author":[{"given":"Patricia","family":"Salvati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Lamberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana G.","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Scampini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Barsotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Patrono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.1995.166_bb0010","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1995.166_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7326\/0003-4819-106-1-79","article-title":"Lupus nephritis","volume":"106","author":"Balow","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.1995.166_bb0020","first-page":"158","article-title":"Diseases of immunity","author":"Kumar","year":"1984"},{"key":"10.1038\/ki.1995.166_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ki.1991.12","article-title":"Enhanced renal leukotriene production in murine lupus: Role of lypoxygenase metabolites","volume":"39","author":"Spurney","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.166_bb0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ki.1991.111","article-title":"Successful treatment of lupus nephritis in MRL-lpr\/lpr mice by inhibiting ornithine decarboxylase","volume":"39","author":"Gunnia","year":"1991","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.166_bb0035","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ki.1990.309","article-title":"Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus","volume":"38","author":"Baldi","year":"1990","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.166_bb0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI112284","article-title":"Increased renal thromboxane production in murine lupus nephritis","volume":"77","author":"Kelley","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1995.166_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0090-6980(91)90090-3","article-title":"Physiologic role for enhanced renal thromboxane production in murine lupus nephritis","volume":"42","author":"Spurney","year":"1991","journal-title":"Prostaglandins"},{"key":"10.1038\/ki.1995.166_bb0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1172\/JCI112053","article-title":"Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus","volume":"76","author":"Patrono","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1995.166_bb0055","first-page":"110P","article-title":"Localization of thromboxane synthase in renal tissues of patients with lupus nephritis","volume":"4","author":"Nakabayashi","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.1995.166_bb0060","first-page":"F1029","article-title":"Contractile effects of TXA2 and endoperoxide analogues on cultured rat glomerular mesangial cells","volume":"251","author":"Men\u00e8","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.1995.166_bb0065","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ki.1992.217","article-title":"Thromboxane synthesis and action within the kidney","volume":"41","author":"Remuzzi","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.166_bb0070","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ki.1993.172","article-title":"Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression","volume":"43","author":"Bruggeman","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.166_bb0075","first-page":"48","article-title":"Thromboxane A2 regulates protein synthesis of cultured human mesangial cells","volume":"120","author":"Men\u00e8","year":"1992","journal-title":"J Lab Med"},{"key":"10.1038\/ki.1995.166_bb0080","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198902163200703","article-title":"Improvement of renal function with selective thromboxane antagonism in lupus nephritis","volume":"320","author":"Pierucci","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1995.166_bb0085","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ki.1992.149","article-title":"Thromboxane receptor blockade reduces renal injury in murine lupus nephritis","volume":"41","author":"Spurney","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.166_bb0090","first-page":"199","article-title":"Cyclophosphamide treatment of mouse systemic lupus erythematosus","volume":"21","author":"Horowitz","year":"1969","journal-title":"Lab Invest"},{"key":"10.1038\/ki.1995.166_bb0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0223-5234(91)90103-T","article-title":"N-imidazolyl derivatives of the napthalene and chroman rings as thromboxane A2 synthase inhibitors","volume":"26","author":"Cozzi","year":"1991","journal-title":"Eur J Med Chem"},{"key":"10.1038\/ki.1995.166_bb0100","first-page":"472","article-title":"Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism","volume":"228","author":"Patrignani","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1038\/ki.1995.166_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(68)92778-5","article-title":"Cyclophosphamide treatment of kidney disease in (NZBxNZW) F1 hybrid mice","volume":"I","author":"Russell","year":"1968","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.166_bb0110","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1016\/S0021-9258(19)68855-1","article-title":"Metabolism of thromboxane B2 in man: Identification of twenty urinary metabolites","volume":"256","author":"Roberts","year":"1981","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.1995.166_bb0115","first-page":"F77","article-title":"Renal metabolism and urinary excretion of thromboxane B2 in the rat","volume":"26","author":"Benigni","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.1995.166_bb0120","series-title":"Classification and Atlas of Glomerular Disease","first-page":"127","article-title":"Renal disease","author":"Churg","year":"1982"},{"key":"10.1038\/ki.1995.166_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/21548331.1980.11946682","article-title":"The immunopathology of SLE","volume":"15","author":"Kunkel","year":"1980","journal-title":"Hosp Pract"},{"key":"10.1038\/ki.1995.166_bb0130","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1172\/JCI113780","article-title":"Local extrahepatic expression of complement genes C3 factor B, C2 and C4 is increased in murine lupus nephritis","volume":"82","author":"Passwell","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1995.166_bb0135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ki.1990.309","article-title":"Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus","volume":"38","author":"Baldi","year":"1990","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.166_bb0140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1984.75","article-title":"Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome","volume":"25","author":"Howard","year":"1984","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.166_bb0145","series-title":"Statistical methods","author":"Snedecor","year":"1974"},{"key":"10.1038\/ki.1995.166_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0197-2456(81)90001-5","article-title":"Introduction to sample size determination and power analysis for clinical trials","volume":"2","author":"Lachin","year":"1981","journal-title":"Controlled Clin Trials"},{"key":"10.1038\/ki.1995.166_bb0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1038\/ki.1995.166_bb0160","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0021-9681(69)90035-6","article-title":"Estimating survival functions from the life table","volume":"21","author":"Gehan","year":"1969","journal-title":"J Chronic Dis"},{"key":"10.1038\/ki.1995.166_bb0165","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI110288","article-title":"Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZBxNZW F1 mice","volume":"68","author":"Prickett","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1995.166_bb0170","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.4049\/jimmunol.134.3.1914","article-title":"A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice","volume":"134","author":"Kelley","year":"1985","journal-title":"J Immunol"},{"key":"10.1038\/ki.1995.166_bb0175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000234732","article-title":"Effect of eicosapentaenoic acid-rich Menhaden oil and MaxEPA on the autoimmune disease of MRL\/lpr mice","volume":"88","author":"Westberg","year":"1989","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1038\/ki.1995.166_bb0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1172\/JCI110056","article-title":"Prevention of glomerulonephritis and prolonged survival in New Zealand Black\/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet","volume":"67","author":"Hurd","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1995.166_bb0185","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1016\/S0021-9258(17)42835-3","article-title":"The effect of eicosapentenoic acid on leukotriene B production by human neutrophils","volume":"259","author":"Prescott","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.1995.166_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90905-8","article-title":"Measurement of renal and non-renal eicosanoid synthesis","volume":"81","author":"Catella","year":"1986","journal-title":"Am J Med"},{"key":"10.1038\/ki.1995.166_bb0195","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/01.CIR.67.6.1174","article-title":"Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease","volume":"67","author":"FitzGerald","year":"1983","journal-title":"Circulation"},{"key":"10.1038\/ki.1995.166_bb0200","first-page":"288","article-title":"The effects of a thromboxane synthase inhibitor, a prostacyclin analog and PGE1 on the nephritis of the NZBxW F1 mouse","volume":"28","author":"Clark","year":"1987","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.1995.166_bb0205","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4049\/jimmunol.143.11.3470","article-title":"Tumor necrosis factor and IL-1 in New Zealand black\/white mice","volume":"143","author":"Brennan","year":"1989","journal-title":"J Immunol"},{"key":"10.1038\/ki.1995.166_bb0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1681\/ASN.V4158","article-title":"Interleukin-6 receptor blockade ameliorates murine lupus nephritis","volume":"4","author":"Kiberd","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.1995.166_bb0215","first-page":"233","article-title":"Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZBxW F1 mice","volume":"16","author":"Nakamura","year":"1993","journal-title":"Renal Physiol Biochem"},{"key":"10.1038\/ki.1995.166_bb0220","first-page":"764","article-title":"Renal endothelin (ET-1) and ETB receptor gene expression in NZB\/NZW F1 mice with lupus nephritis","volume":"4","author":"Benatti","year":"1993","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815589308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815589308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T12:35:12Z","timestamp":1707914112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815589308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["S0085253815589308"],"URL":"https:\/\/doi.org\/10.1038\/ki.1995.166","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}